SCHEMBL1237323

SCHEMBL1237323

CCCC/C=C1\CCCC1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.44
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.38
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PRKCA P17252 2/20 0.35
TSHR P16473 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C1 Q04828 1/20 0.34
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1042088 1.00 CCR6 (0.44) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL25320364 1.00 CCR6 (0.44) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL9404901 0.96 CCR6 (0.44) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL9404904 0.96 CCR6 (0.44) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL440372 0.94 PRKCA (0.40) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL440371 0.94 PRKCA (0.40) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL20608590 0.94 PRKCA (0.40) CCR6RAB9AKDM4EL3MBTL1TP53
SCHEMBL812328 0.92 PRKCA (0.42) CCR6PRKCATSHR
SCHEMBL6897541 0.92 PRKCA (0.42) CCR6PRKCATSHR
SCHEMBL809687 0.92 PRKCA (0.42) CCR6PRKCATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5081310-A PROCESS FOR PREPARING OPTICALLY ACTIVE KETONES TAKASAGO INTERNATIONAL CORPORATION (JP) 1992-01-14 US claimed
US-4175087-A ENAMINOKETONES WITH ALKYLLITHIUM ELI LILLY AND COMPANY (US) 1979-11-20 US claimed
JP-6080606-A None JP disclosed
JP-3048634-A None JP disclosed
US-12503668-B2 Odorant compound FIRMENICH SA (CH) 2025-12-23 US disclosed
CN-119912322-A Continuous preparation method of 2-pentylene cyclopentanone 江苏宏邦化工科技有限公司 2025-05-02 CN disclosed
US-20250121362-A1 NOVEL COMPOSITIONS FOR THE SUSTAINABLE CATALYSIS OF ORGANIC SYNTHESIS REACTIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-04-17 US disclosed
US-20240409486-A1 COMPOUND PRODUCING METHOD INCLUDING STEP OF ISOMERIZING ALPHA, BETA-UNSATURATED KETONE KAO CORPORATION (JP) 2024-12-12 US disclosed
EP-4469200-A1 NOVEL COMPOSITIONS FOR THE SUSTAINABLE CATALYSIS OF ORGANIC SYNTHESIS REACTIONS Centre National de la Recherche Scientifique (FR) 2024-12-04 EP disclosed
CN-117964471-A Preparation method and reaction device of 2-pentylene cyclopentanone 江苏宏邦化工科技有限公司 2024-05-03 CN disclosed
EP-3475256-B1 DEHYDROGENATION REACTION FIRMENICH & CIE (CH) 2024-01-24 EP disclosed
EP-1316541-A1 Process for producing 2-alkyl-2-cyclopentenones Takasago International Corporation (JP) 2003-06-04 EP disclosed
CN-1155880-A Process for obtaining unsautrated cycloaliphatic ketones FIRMENICH & CIE (CH) 1997-07-30 CN disclosed
JP-H0680606-A PRODUCTION OF 2-ALKYL-2-CYCLOPENTENONE KAO CORP 1994-03-22 JP disclosed
EP-0409530-B1 Catalytic preparation of optically active ketones TAKASAGO PERFUMERY CO LTD (JP) 1993-12-08 EP disclosed
US-5081310-A PROCESS FOR PREPARING OPTICALLY ACTIVE KETONES TAKASAGO INTERNATIONAL CORPORATION (JP) 1992-01-14 US disclosed
JP-H0348634-A PRODUCTION OF OPTICALLY ACTIVE KETONE TAKASAGO INTERNATL CORP 1991-03-01 JP disclosed
EP-0409530-A1 Catalytic preparation of optically active ketones Takasago International Corporation (JP) 1991-01-23 EP disclosed
US-4496766-A FROM AN A-DISUBSTITUTED-8-KETO ACID ESTER; USING A CATALYST COMPLEX OF A PALLADIUM COMPOUND AND A PHOSPHINE NIPPON ZEON CO. LTD. (JP) 1985-01-29 US disclosed
US-4175087-A ENAMINOKETONES WITH ALKYLLITHIUM ELI LILLY AND COMPANY (US) 1979-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503668-B2 Odorant compound TRPA1, ACLY, CYP3A5 CCR6 1189/4885RAB9A 4682/4885KDM4E 2938/4885
US-20250121362-A1 NOVEL COMPOSITIONS FOR THE SUSTAINABLE CATALYSIS OF ORGANIC SYNTHESIS REACTIONS KHK, KCNK10, KCNK2 CCR6 4422/4885RAB9A 2717/4885KDM4E 175/4885
US-20240409486-A1 COMPOUND PRODUCING METHOD INCLUDING STEP OF ISOMERIZING ALPHA, BETA-UNSATURATED KETONE CBR1, AKR1B1, AKR1C1 CCR6 1079/4885RAB9A 3911/4885KDM4E 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.